Evaluation of Foquest in Adults 65 Years and Older With ADHD

NCT07710014 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

36

Enrollment

NETWORK

Sponsor class

Conditions

Attention Deficit Hyperactivity Disorder

Interventions

DRUG: Methylphenidate hydrochloride extended-release capsules

Sponsor

Dar Clinical Research Inc.